<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Koninklijke Philips N.v. — News on 6ix</title>
    <link>https://6ix.com/company/koninklijke-philips-nv-1</link>
    <description>Latest news and press releases for Koninklijke Philips N.v. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 02 Apr 2026 12:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/koninklijke-philips-nv-1" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d54aa8beedb30cb6f76737.webp</url>
      <title>Koninklijke Philips N.v.</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1</link>
    </image>
    <item>
      <title>MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/mdic-appoints-philips-chief-medical-officer-carla-goulart-peron-as-new-board-member-33</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/mdic-appoints-philips-chief-medical-officer-carla-goulart-peron-as-new-board-member-33</guid>
      <pubDate>Thu, 02 Apr 2026 12:00:00 GMT</pubDate>
      <description>Carla Goulart Peron, MD, Chief Medical Officer at Royal Philips Carla Goulart Peron, MD, Chief Medical Officer at Royal Philips April 2, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the Board of Directors of the Medical Device Innovation Consortium (MDIC). Founded in 2012, MDIC is a unique public-private partnership that brings sta</description>
    </item>
    <item>
      <title>FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/fda-clears-philips-ai-solution-that-provides-real-time-guidance-during-complex-minimally-invasive-heart-valve-repair-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/fda-clears-philips-ai-solution-that-provides-real-time-guidance-during-complex-minimally-invasive-heart-valve-repair-1</guid>
      <pubDate>Thu, 26 Mar 2026 13:10:00 GMT</pubDate>
      <description>Physician using DeviceGuide with EchoNavigator 5 Physician using DeviceGuide with EchoNavigator 5 Philips DeviceGuide with EchoNavigator 5 Screen Philips DeviceGuide with EchoNavigator 5 Screen DeviceGuide with EchoNavigator 5 DeviceGuide with EchoNavigator 5 March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with Philips Azurion image-guided therapy pl</description>
    </item>
    <item>
      <title>Philips launches IntraSight Plus to simplify coronary interventions and advance precision care</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-launches-intrasight-plus-to-simplify-coronary-interventions-and-advance-precision-care-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-launches-intrasight-plus-to-simplify-coronary-interventions-and-advance-precision-care-1</guid>
      <pubDate>Wed, 25 Mar 2026 09:00:00 GMT</pubDate>
      <description>Philips IntraSight Plus Philips IntraSight Plus Philips IntraSight Plus screen Philips IntraSight Plus screen Team Germany IntraSight Team Germany IntraSight March 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enabl</description>
    </item>
    <item>
      <title>Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-remains-no-1-in-medtech-at-european-patent-office-and-the-largest-dutch-patent-applicant-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-remains-no-1-in-medtech-at-european-patent-office-and-the-largest-dutch-patent-applicant-1</guid>
      <pubDate>Tue, 24 Mar 2026 08:30:00 GMT</pubDate>
      <description>Dual AI engines in SmartSpeed Precise Dual AI engines in SmartSpeed Precise Philips LumiGuide 3D device guidance in use Philips LumiGuide 3D device guidance in use Philips Verida spectral CT system, angle view Philips Verida spectral CT system, angle view i9000 Prestige i9000 Prestige March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips’ platform-based solutions</description>
    </item>
    <item>
      <title>Philips convenes the Annual General Meeting of Shareholders 2026</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-convenes-the-annual-general-meeting-of-shareholders-2026-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-convenes-the-annual-general-meeting-of-shareholders-2026-1</guid>
      <pubDate>Mon, 23 Mar 2026 09:30:00 GMT</pubDate>
      <description>Roy Jakobs Roy Jakobs John DeFord John DeFord Paul Stoffels Paul Stoffels Herna Verhagen Herna Verhagen Sanjay Poonen Sanjay Poonen March 23, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of t</description>
    </item>
    <item>
      <title>Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-proposes-new-appointment-and-re-appointments-to-its-supervisory-board-and-ceo-re-appointment-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-proposes-new-appointment-and-re-appointments-to-its-supervisory-board-and-ceo-re-appointment-1</guid>
      <pubDate>Mon, 23 Mar 2026 08:30:00 GMT</pubDate>
      <description>Roy Jakobs Roy Jakobs John DeFord John DeFord Paul Stoffels Paul Stoffels Herna Verhagen Herna Verhagen Sanjay Poonen Sanjay Poonen March 23, 2026 John DeFord proposed as new member of the Supervisory Board.Paul Stoffels, Herna Verhagen and Sanjay Poonen proposed for re-appointment as members of the Supervisory Board.Marc Harrison will step down from Philips’ Supervisory Board after his second term.Roy Jakobs proposed for re-appointment as President/CEO and Chairman and member of the Board of Ma</description>
    </item>
    <item>
      <title>Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-expands-digital-pathology-portfolio-with-cloud-enabled-philips-intellisite-pathology-solution-on-healthsuite-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-expands-digital-pathology-portfolio-with-cloud-enabled-philips-intellisite-pathology-solution-on-healthsuite-1</guid>
      <pubDate>Wed, 11 Mar 2026 15:00:00 GMT</pubDate>
      <description>Clinician reviewing digital pathology slide Clinician reviewing digital pathology slide March 11, 2026 Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, impr</description>
    </item>
    <item>
      <title>Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-connects-patient-monitoring-and-diagnostics-to-advance-platform-based-care-intelligence-at-himss26-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-connects-patient-monitoring-and-diagnostics-to-advance-platform-based-care-intelligence-at-himss26-1</guid>
      <pubDate>Tue, 10 Mar 2026 15:00:00 GMT</pubDate>
      <description>Nurses at central monitoring station Nurses at central monitoring station Integrated Diagnostics, radiology and pathology Integrated Diagnostics, radiology and pathology March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together a</description>
    </item>
    <item>
      <title>Philips Sonicare unveils two new electric toothbrush ranges alongside refreshed brand direction</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-sonicare-unveils-two-new-electric-toothbrush-ranges-alongside-refreshed-brand-direction-23</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-sonicare-unveils-two-new-electric-toothbrush-ranges-alongside-refreshed-brand-direction-23</guid>
      <pubDate>Thu, 05 Mar 2026 14:00:00 GMT</pubDate>
      <description>Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in oral healthcare, today unveiled two new Philips Sonicare electric toothbrush ranges, the integration of Next-Generation Sonicare technology, along with branding, packaging and sustainability updates that all reflect the brand&apos;s bold new platform, &quot;Feel the Care.&quot; The refreshed brand and product lineup is designed to inspire consumers to elevate their daily oral care routine with advanced brushing technology.</description>
    </item>
    <item>
      <title>Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-unveils-rembra-ct-at-ecr-2026-setting-a-new-benchmark-for-speed-and-patient-access-designed-to-support-diagnostic-confidence-for-acute-and-high-demand-imaging-environments-7</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-unveils-rembra-ct-at-ecr-2026-setting-a-new-benchmark-for-speed-and-patient-access-designed-to-support-diagnostic-confidence-for-acute-and-high-demand-imaging-environments-7</guid>
      <pubDate>Wed, 04 Mar 2026 09:35:00 GMT</pubDate>
      <description>Philips unveils Rembra CT at ECR 2026 Philips unveils Rembra CT at ECR 2026 Philips Rembra, a next-generation radiology CT system designed for the realities of acute and high-demand imaging Philips Rembra, a next-generation radiology CT system designed for the realities of acute and high-demand imaging March 4, 2026 CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to su</description>
    </item>
    <item>
      <title>Koninklijke Philips Enterprise Technology Analysis Report 2025: Digital Transformation Strategies, Innovation Programs, Technology Initiatives, Partnerships, Investment &amp; Acquisition, Network Map</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/koninklijke-philips-enterprise-technology-analysis-report-2025-digital-transformation-strategies-innovation-programs-technology-initiatives-partnerships-investment-and-acquisition-network-map-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/koninklijke-philips-enterprise-technology-analysis-report-2025-digital-transformation-strategies-innovation-programs-technology-initiatives-partnerships-investment-and-acquisition-network-map-1</guid>
      <pubDate>Wed, 25 Feb 2026 09:05:00 GMT</pubDate>
      <description>Koninklijke Philips NV presents market opportunities in precision diagnosis, image-guided therapy, sleep and respiratory care, and personal health. The company is leveraging digital transformation, innovation programs, and strategic technology initiatives, including partnerships and product launches, to enhance its offerings.Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The &quot;Enterprise Tech Ecosystem Series: Koninklijke Philips N.V. 2025&quot; company profile has been added to ResearchAndMarkets.com&apos;s of</description>
    </item>
    <item>
      <title>Philips publishes its Annual Report 2025</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-publishes-its-annual-report-2025-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-publishes-its-annual-report-2025-1</guid>
      <pubDate>Thu, 19 Feb 2026 09:00:00 GMT</pubDate>
      <description>February 19, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets</description>
    </item>
    <item>
      <title>Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-introduces-inkspace-imagings-snuggletm-flexible-pediatric-mri-coil-for-its-30t-mr-systems-helping-to-enhance-imaging-precision-efficiency-and-comfort-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-introduces-inkspace-imagings-snuggletm-flexible-pediatric-mri-coil-for-its-30t-mr-systems-helping-to-enhance-imaging-precision-efficiency-and-comfort-1</guid>
      <pubDate>Thu, 12 Feb 2026 14:00:00 GMT</pubDate>
      <description>Designed for Pediatric Comfort Designed for Pediatric Comfort Flexible, High Density Coil Design Flexible, High Density Coil Design Child Centered Innovation for 3.0T MRI Child Centered Innovation for 3.0T MRI February 12, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients,</description>
    </item>
    <item>
      <title>Philips delivers full year 2025 with growth acceleration, strong margin expansion and solid cash flow; announces 2026-2028 targets at Capital Markets Day</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-delivers-full-year-2025-with-growth-acceleration-strong-margin-expansion-and-solid-cash-flow-announces-2026-2028-targets-at-capital-markets-day-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-delivers-full-year-2025-with-growth-acceleration-strong-margin-expansion-and-solid-cash-flow-announces-2026-2028-targets-at-capital-markets-day-1</guid>
      <pubDate>Tue, 10 Feb 2026 06:00:00 GMT</pubDate>
      <description>Amsterdam, February 10, 2026Full year and Q4 highlights Comparable order intake growth 6% in 2025; up 7% in Q4Group sales of EUR 17.8 billion in 2025, EUR 5.1 billion in Q4; comparable sales growth 2% in 2025, 7% in Q4Income from operations was EUR 1,424 million in 2025; EUR 540 million in Q4Adjusted EBITA margin increased 80 basis points to 12.3% of sales in 2025; up 160 basis points to 15.1% in Q4Operating cash flow of EUR 1,172 million in 2025; EUR 1,391 million in Q4Free cash flow of EUR 512</description>
    </item>
    <item>
      <title>Philips proposes to re-appoint CEO Roy Jakobs</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-proposes-to-re-appoint-ceo-roy-jakobs-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-proposes-to-re-appoint-ceo-roy-jakobs-1</guid>
      <pubDate>Tue, 10 Feb 2026 05:55:00 GMT</pubDate>
      <description>Roy Jakobs, CEO Royal Philips Roy Jakobs, CEO Royal Philips February 10, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive Officer and member of the Board of Management. The decision to propose the re-appointment of Roy Jakobs reflects the Supervisory Board’s recognition of the progress made since 2022 and its confidence in his leadership as</description>
    </item>
    <item>
      <title>Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-named-a-clarivate-top-100-global-innovator-for-the-13th-consecutive-year-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-named-a-clarivate-top-100-global-innovator-for-the-13th-consecutive-year-1</guid>
      <pubDate>Wed, 21 Jan 2026 10:00:00 GMT</pubDate>
      <description>Improved image and data acquisition Improved image and data acquisition Philips Verida spectral CT system, angle view Philips Verida spectral CT system, angle view Radiologist using web diagnostic viewer Radiologist using web diagnostic viewer i9000 Prestige feature image i9000 Prestige feature image January 21, 2026 Highest-ranking medical technology company recognized in the Clarivate Top 100 Global Innovators list for 2026Innovations for healthcare professionals and consumers that support bet</description>
    </item>
    <item>
      <title>Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-agrees-to-acquire-spectrawave-inc-advancing-next-generation-coronary-intravascular-imaging-and-physiological-assessment-with-ai-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-agrees-to-acquire-spectrawave-inc-advancing-next-generation-coronary-intravascular-imaging-and-physiological-assessment-with-ai-1</guid>
      <pubDate>Mon, 15 Dec 2025 07:00:00 GMT</pubDate>
      <description>Clinician and patient with Azurion and IntraSight Clinician and patient with Azurion and IntraSight DeepOCT Enhanced Vascular Imaging DeepOCT Enhanced Vascular Imaging Philips and SpectraWAVE logos Philips and SpectraWAVE logos December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR tech</description>
    </item>
    <item>
      <title>Philips reiterates timing of 2026 outlook</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-reiterates-timing-of-2026-outlook-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-reiterates-timing-of-2026-outlook-1</guid>
      <pubDate>Thu, 04 Dec 2025 12:14:00 GMT</pubDate>
      <description>December 4, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales grow</description>
    </item>
    <item>
      <title>XENOVIEW® 3T coil passes Philips compatibility testing</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/xenoviewr-3t-coil-passes-philips-compatibility-testing-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/xenoviewr-3t-coil-passes-philips-compatibility-testing-1</guid>
      <pubDate>Mon, 01 Dec 2025 14:04:00 GMT</pubDate>
      <description>Polarean’s FDA cleared coil achieves important milestone, expanding clinical reach XENOVIEW® 3T coil passes Philips compatibility testing XENOVIEW® 3T Chest Coil is now confirmed for integration with Philips MRI systems starting in 2026 DURHAM, NC and LONDON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, announces that its FDA-cleared XENOVIEW® 3T Chest Coil has successfull</description>
    </item>
    <item>
      <title>Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy</title>
      <link>https://6ix.com/company/koninklijke-philips-nv-1/news/philips-expands-commercial-availability-of-worlds-first-real-time-ai-enabled-light-based-3d-navigation-solution-for-image-guided-therapy-1</link>
      <guid isPermaLink="true">https://6ix.com/company/koninklijke-philips-nv-1/news/philips-expands-commercial-availability-of-worlds-first-real-time-ai-enabled-light-based-3d-navigation-solution-for-image-guided-therapy-1</guid>
      <pubDate>Mon, 01 Dec 2025 13:00:00 GMT</pubDate>
      <description>Philips LumiGuide 3D device guidance in use Philips LumiGuide 3D device guidance in use December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Nether</description>
    </item>
  </channel>
</rss>